Third Rock-backed star­tup's blood test can sniff out can­cer in pa­tients with no his­to­ry of dis­ease

The myr­i­ad of liq­uid biop­sy com­pa­nies work­ing on blood tests for ear­ly can­cer de­tec­tion have been con­duct­ing ret­ro­spec­tive stud­ies, look­ing at how ef­fec­tive and sen­si­tive their tech­nol­o­gy is in spot­ting can­cer in pa­tients that have al­ready been di­ag­nosed. Now, a Third Rock Ven­tures-backed start­up has al­so shown its blood test can per­form in a large prospec­tive study in­volv­ing pa­tients with no per­son­al his­to­ry of can­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER